RUNX3 Expression Is an Independent Prognostic Factor in Cytogenetically Abnormal Adult Acute Myeloid Leukemia (AML) Patients with Wild-Type FLT3

被引：0
|
作者：
Kwan, Tsz-Ki [1 ]
Cheng, Chi-Keung [1 ]
Cheng, Suk-Hang [1 ]
Chan, Natalie P. H. [1 ]
Ip, Rosalina [1 ]
Wong, Raymond S. M. [2 ]
Yip, Sze-Fai [3 ]
Li, Chi-Kong [4 ]
Ng, Margaret H. L. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[3] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[4] Prince Wales Hosp, Children Canc Ctr, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：697 / 698
页数：2
相关论文
共 50 条
  • [31] Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia
    Choi, Y
    Kim, HJ
    Park, BH
    Min, WS
    Kim, CC
    LEUKEMIA, 2005, 19 (01) : 141 - 143
  • [32] Midostaurin for Patients With Acute Myeloid Leukemia and FLT3 Mutations
    Levis, Mark James
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (06) : 323 - 325
  • [33] Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia
    Guo, R. J.
    Atenafu, E. G.
    Schimmer, A. D.
    Minden, M. D.
    Chang, H.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (04) : 429 - 437
  • [34] First in Human (FIH) FLT3 and SYK Inhibitor HM43239 Shows Single Agent Activity in Patients (pts) with Relapsed or Refractory (R/R) FLT3 Mutated and Wild-Type Acute Myeloid Leukemia (AML)
    Daver, Naval
    Lee, Kyoo Hyung
    Jung, Chul Won
    Yoon, Sung-Soo
    Arellano, Martha L.
    Yoon, Jiyeon
    Lee, Nora
    Kim, Hyunjin
    Lee, Jaeyeon
    Jonas, Brian A.
    Baek, Seungjae
    BLOOD, 2021, 138
  • [35] Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia
    Dicker, Frank
    Haferlach, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    BLOOD, 2007, 110 (04) : 1308 - 1316
  • [36] Detailed analysis of FLT3 expression levels in acute myeloid leukemia
    Kuchenbauer, Florian
    Kern, Wolfgang
    Schoch, Claudia
    Kohlmann, Alexander
    Hiddemann, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    HAEMATOLOGICA, 2005, 90 (12) : 1617 - 1625
  • [37] Gilteritinib Reduces FLT3 Expression in Acute Myeloid Leukemia Cells
    Thai, Thi Lam
    Han, Sun-Young
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (05) : 577 - 581
  • [38] Effect of vorinostat use on survival in patients with acute myeloid leukemia (AML) with FLT3 ITD mutations
    Chae, Young Kwang
    Dimou, Anastasios
    Takahashi, Koichi
    Benton, Christopher Brent
    Jabbour, Elias
    Ravandi, Farhad
    Borthakur, Gautam
    Cortes, Jorge E.
    Kadia, Tapan M.
    Thomas, Deborah A.
    Wierda, William G.
    Daver, Naval Guastad
    Dinardo, Courtney Denton
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia
    Shamaa, Sameh
    Laimon, Nabil
    Aladle, Doaa A.
    Azmy, Emad
    Elghannam, Doaa M.
    Salem, Dalia A.
    Taalab, Mona M.
    HEMATOLOGY, 2014, 19 (01) : 22 - 30
  • [40] PROGNOSTIC SIGNIFICANCE OF FLT3 MUTATIONS IN NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA PATIENTS IN INDIA
    Kumar, B.
    Hasan, K. Syed
    Sharma, V.
    Asthana, B.
    Kumar, R.
    Anand, H.
    Mahapatra, M.
    Saxena, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 545 - 545
12345